Literature DB >> 8406818

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern.

J P de Boer1, A A Creasey, A Chang, D Roem, A J Eerenberg, C E Hack, F B Taylor.   

Abstract

Activation of the complement system was studied in baboons that were challenged with live Escherichia coli. In the group challenged with a lethal dose (n = 4), the complement activation parameters C3b/c, C4b/c, and C5b-9 increased 13, 5, and 12 times the baseline value, respectively, during the first 6 h after the E. coli infusion, whereas in the group challenged with a sublethal dose (n = 10), they increased only moderately, by 2 to 3 times the baseline value. However, in this latter group, a more pronounced activation occurred at 24 h. Subsequent experiments showed that this second phase in complement activation started at 6 h after the challenge, at which time infused microorganisms had been cleared from the circulation. The simultaneous increase in C-reactive protein with this second phase suggested an endogenous activation mechanism involving this acute-phase protein. Levels of inactivated (modified) C1 inhibitor also increased in both groups, with peak levels of 2.5 times the baseline value at 24 h in the sublethal group and of 4 times at 6 h after the challenge in the lethal group. Thus, activation of complement in this animal model for sepsis occurs in a biphasic pattern, the initial phase mediated by the bacteria and the later phase mediated by an endogenous mechanism possibly involving C-reactive protein. The differences in complement activation between animals with lethal or sublethal sepsis support the hypothesis that complement activation contributes to the lethal complications of sepsis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406818      PMCID: PMC281157          DOI: 10.1128/iai.61.10.4293-4301.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.

Authors:  E S Kalter; M R Daha; J W ten Cate; J Verhoef; B N Bouma
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

2.  On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity.

Authors:  T Wiedmer; C T Esmon; P J Sims
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

Review 3.  Molecular biology and chemistry of the alternative pathway of complement.

Authors:  H J Müller-Eberhard; R D Schreiber
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

4.  Anaphylatoxin formation in sepsis.

Authors:  A Bengtson; M Heideman
Journal:  Arch Surg       Date:  1988-05

5.  C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.

Authors:  S Okusawa; C A Dinarello; K B Yancey; S Endres; T J Lawley; M M Frank; J F Burke; J A Gelfand
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

6.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

Authors:  F B Taylor; A Chang; C T Esmon; A D'Angelo; S Vigano-D'Angelo; K E Blick
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

7.  A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.

Authors:  C E Hack; A J Hannema; A J Eerenberg-Belmer; T A Out; R C Aalberse
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

8.  Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase.

Authors:  M S Brower; P C Harpel
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

9.  Terminal complement complexes and anaphylatoxins in septic and ischemic patients.

Authors:  M Heideman; B Norder-Hansson; A Bengtson; T E Mollnes
Journal:  Arch Surg       Date:  1988-02

10.  Detection of the 'hyperdynamic state' of sepsis in the baboon during lethal E. coli infusion.

Authors:  L B Hinshaw; D J Brackett; L T Archer; B K Beller; M F Wilson
Journal:  J Trauma       Date:  1983-05
View more
  15 in total

1.  Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.

Authors:  R F Guo; M Huber-Lang; X Wang; V Sarma; V A Padgaonkar; R A Craig; N C Riedemann; S D McClintock; T Hlaing; M M Shi; P A Ward
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Modern complement analysis.

Authors:  Michael Kirschfink; Tom E Mollnes
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

Review 3.  New insights into cellular mechanisms during sepsis.

Authors:  Laszlo M Hoesel; Hongwei Gao; Peter A Ward
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.

Authors:  Robert Silasi-Mansat; Hua Zhu; Narcis I Popescu; Glenn Peer; Georgia Sfyroera; Paola Magotti; Lacramioara Ivanciu; Cristina Lupu; Tom E Mollnes; Fletcher B Taylor; Gary Kinasewitz; John D Lambris; Florea Lupu
Journal:  Blood       Date:  2010-05-13       Impact factor: 22.113

Review 6.  C1 inhibitor: molecular and clinical aspects.

Authors:  Marco Cicardi; Lorenza Zingale; Andrea Zanichelli; Emanuela Pappalardo; Benedetta Cicardi
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

7.  Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates.

Authors:  Tolga Sursal; Deborah J Stearns-Kurosawa; Kiyoshi Itagaki; Sun-Young Oh; Shiqin Sun; Shinichiro Kurosawa; Carl J Hauser
Journal:  Shock       Date:  2013-01       Impact factor: 3.454

8.  Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.

Authors:  J P de Boer; A A Creasey; A Chang; J J Abbink; D Roem; A J Eerenberg; C E Hack; F B Taylor
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 9.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Complement activation in relation to capillary leakage in children with septic shock and purpura.

Authors:  J A Hazelzet; R de Groot; G van Mierlo; K F Joosten; E van der Voort; A Eerenberg; M H Suur; W C Hop; C E Hack
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.